CNBC reports that HHS plans to appoint two new FDA deputy commissioners in hopes of exerting more influence over the agency.
FDA says the Boston Scientific recall of its ENROUTE Transcarotid Neuroprotection System is Class 1.
CNBC reports that HHS plans to appoint two new FDA deputy commissioners in hopes of exerting more influence over the agency.
FDA says the Boston Scientific recall of its ENROUTE Transcarotid Neuroprotection System is Class 1.
Participants in a 4/23 FDA meeting on increasing access to nonprescription drugs see a need to improve the electronic health record capture of information about nonprescription drug use.
An oncology physician association says its members are reporting a shortage of the chemotherapy agent ifosfamide for which no direct substitute is available.
